Dipexium Pharmaceut (DPRX) Misses Q1 EPS by 5c

Dipexium Pharmaceut (NASDAQ: DPRX) reported Q1 EPS of ($0.49), $0.05 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Dipexium Pharmaceut (DPRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat